Epsilon M&A Deal Report - Mitim
Transaction Multiples for the Valuation of Private Companies
Recipharm Italia > Mitim
Announced Date : 23 February 2016
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Recipharm Italia
Target: Mitim
Target Country: Italy
Sector of activity : Health, Pharmaceuticals & Biotechnology
Business Description :
> Mitim is a pharmaceutical contract manufacturing company loca ...
Transaction multiples available
| EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
|---|---|---|---|---|---|---|---|
| Historic | |||||||
| Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating ***
Source: Epsilon Research / EMAT
Comparable Transactions
Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226
Example of comparable transactions on EMAT (same sub-sector):
| Date | Acquirer | Target | Country | Multiples | See details |
|---|---|---|---|---|---|
| 01/05/2010 | Private Group led by Galia Gestion | Gabilly (now Lyamtech) | France | 0 | |
| 21/05/2013 | Össur hf | TeamOlmed Syd | Sweden | 0 |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database
